AstraZeneca to Establish $1.5 Billion ADC Manufacturing Facility in Singapore
AstraZeneca has announced plans to construct a $1.5 billion manufacturing facility in Singapore dedicated to producing antibody-drug conjugates (ADCs), a …
#Biopharma news
Altasciences Boosts Life-Saving Drug Development with Proscia's Digital Pathology Platform
In a strategic move to improve the drug development process, Altasciences has partnered with Proscia, a leading provider of digital …
Proscia Enhances Preclinical R&D Platform: Streamlining Pathology Workflows for Faster Drug Safety Decisions
Proscia, a company specializing in digital and computational pathology solutions, recently announced updates to its preclinical research and development (R&D) …
Covid-19 Vaccines in Development and Use (List Not Updated)
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is a …
What are the ADC drugs?
The antibody-drug conjugates (ADCs) market continues to rise globally, but ADCs are not a new thing. Why has ADC been surging …
Pharma Companies Join Forces to Train AI for Drug Discovery Using Blockchain
The newly organized research project “MELLODDY” (Machine Learning Ledger Orchestration for Drug Discovery), involving ten large pharma companies and seven …
Genetic Test for Antimicrobial Resistance
Scientists have put together a sensitive method to determine if bacteria carry a gene that can cause resistance to two …
New Liposome Treatment for Community-acquired Pneumonia
New research, published in The Lancet Infectious Diseases, presents the first clinical results with CAL02 in patients suffering from severe …
Artificial Intelligence Yields Early Results in Drug Discovery
A historically significant milestone has just been reached by Oxford, UK-based Exscientia, which used its artificial intelligence (AI)-based drug discovery …
Confluence of Technologies Can Bring “Virtual Pharmacology” to the Next Level
In 1970-80s, the idea of virtual screening was regarded as a conceptual way to substitute costly and time-consuming experimental “screen-everything-you-have” …
Presenting a New Paradigm for Drug Discovery: Combining Computational Biophysics and AI through MatchMaker
In this Special Perspective, our fourth in an ongoing series, we will be presenting MatchMaker™, a novel deep proteome screening …
Pharma and Healthcare AI Vendors Join Forces To Accelerate Progress In Drug Discovery
Today Basel is crowded with some of the top business and research leaders representing a young and rapidly growing industry …